All data are based on the daily closing price as of February 9, 2026
a

Asahi Kasei

3407.TSE
11.17 USD
0.37
+3.43%

Overview

Last close
11.17 usd
Market cap
15.18B usd
52 week high
11.17 usd
52 week low
6.20 usd
Target price
10.2 usd

Valuation

P/E
16.8313
Forward P/E
N/A
Price/Sales
0.7767
Price/Book Value
1.1488
Enterprise Value
19.18B usd
EV/Revenue
0.9899
EV/EBITDA
7.5388

Key financials

Revenue TTM
19.41B usd
Gross Profit TTM
6.31B usd
EBITDA TTM
2.67B usd
Earnings per Share
0.66 usd
Dividend
0.26 usd
Total assets
26.59B usd
Net debt
4.68B usd

About

Asahi Kasei Corporation engages in material, homes, healthcare businesses. The company offers Pimel photosensitive polyimide/PBO precursor, a liquid photosensitive material for buffer coating and packaging applications; Sunfort dry film photoresist to form circuit patterns on printed wiring boards; Novacure, a latent curing agent for epoxy resin with storage stability; glass fabric for printed circuit boards; plastic optical fiber; suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; Hipore, a microporous polyolefin sheet which prevents the anode and cathode from contacting one another; Celgard, a lithium-ion battery separator; Deramic, a lead acid battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, ROICA, ELTAS, Bemliese, EUTEC, Precisé, SEMIA, smash, PULSHUT, Lastan, Cubit, NanoAct, ECORISE, BioCradle, CMC-Bemliese names. It also provides cling film, bags and containers, and dishwashing liquid under the Saran Wrap, Ziploc, Cookper, Frosch names; packaging products under the OPS, Suntec, Barrialon, PVDC latex, and Saran names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company is involved in the provision of remodeling services; real estate-related operations; offers unit homes and apartment buildings; autoclaved aerated concrete, foundation systems, thermal insulation material, structural systems and components products; prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; enzymes and diagnostic products; and hemodialysis, therapeutic apheresis, and autologous blood-related businesses. The company was founded in 1931 and is headquartered in Tokyo, Japan.
  • Symbol
    3407.TSE
  • Exchange
    TSE
  • Isin
    JP3111200006
  • Country
    Japan
  • Sector
    Industrials
  • Industry
    Conglomerates
  • CEO
    Dr. Ichiro Oyama M.D.
  • Headquarter
    Tokyo
  • Web site
    https://www.asahi-kasei.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top